Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5774748

O=C(CCc1cnoc1-c1ccc(F)cc1)N1CCN(c2ccccn2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
KDM4E B2RXH2 6/20 0.50
HSD17B10 Q99714 4/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50
RECQL P46063 1/20 0.50
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
GLA P06280 1/20 0.47
NPC1 O15118 2/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46
GRM5 P41594 1/20 0.45
ME2 P23368 1/20 0.45
ME1 P48163 1/20 0.45
ME3 Q16798 1/20 0.45
PARP1 P09874 1/20 0.45
HTR7 P34969 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5776691 0.90 GRM5 (0.48) ALDH1A1KDM4ESMN1; SMN2NPC1TSHR
Trifluoroacetic Acid SCHEMBL5772610 0.88 GFER (0.53) RAB9ANPC1TSHRKMT2APARP1
Trifluoroacetic Acid SCHEMBL5777433 0.86 GFER (0.53) ALDH1A1HSD17B10HPGDRAB9ANPC1
Trifluoroacetic Acid SCHEMBL5775321 0.86 KMT2A (0.53) ALDH1A1RAB9ASMN1; SMN2NPC1TSHR
Trifluoroacetic Acid SCHEMBL5776836 0.85 PARP1 (0.44) TSHRKMT2APARP1HTR7L3MBTL1
Trifluoroacetic Acid SCHEMBL5775195 0.84 ATM (0.49) KMT2AL3MBTL1
Trifluoroacetic Acid SCHEMBL5776834 0.84 HTT (0.46) HPGDSMN1; SMN2KMT2AME2ME1
Trifluoroacetic Acid SCHEMBL5770010 0.83 HTR1A (0.49) ALDH1A1KDM4EHSD17B10SMN1; SMN2TSHR
Trifluoroacetic Acid SCHEMBL5776822 0.83 DPP8 (0.50) ALDH1A1TSHRKMT2A
Trifluoroacetic Acid SCHEMBL5777370 0.83 L3MBTL1 (0.55) ALDH1A1RAB9ATSHRKMT2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR ALDH1A1 1045/4885KDM4E 3953/4885HSD17B10 305/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 ALDH1A1 682/4885KDM4E 3347/4885HSD17B10 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.